Chimp virus plays key role in malaria vaccine

A new blend of a genetically modified chimp adenovirus and a malaria gene is proving promising as a potential vaccine against malaria. The adenovirus is used to spur an immune response against malaria, a disease that claims a host of lives each year. By turning to a chimp adenovirus the Oxford University scientists say they can avoid the immunity built up in people against human adenoviruses. Governments set out in 2000 to halve the death rate from malaria by 2010, but there's little hope of reaching that goal without an effective vaccine. The Oxford team says that they believe that they could be within five years of a new vaccine.

- read the article from the BBC

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.